Company Profile for Arterial Remodeling Technologies

Company Profile for Arterial Remodeling Technologies

--(BUSINESS WIRE)-- Arterial Remodeling Technologies ("ART") is developing a bioresorbable polymer stent that promotes the natural remodeling of an injured artery after angioplasty. The Company's technology is based on intellectual property originating from three esteemed institutions: the Cleveland Clinic (Cleveland, Ohio); the French national research institute, C.N.R.S. (Centre National de Recherche Scientifique), Montpellier, France; and, Necker University, Paris. ART's bioresorbable stent is designed to dismantle in vivo over an optimized time horizon, thus allowing the body's own natural arterial remodeling process to occur, unrestricted by the presence of a permanent metallic stent.

Company:

Arterial Remodeling Technologies

Headquarters Address:

3, rue de Verdun - Bât.G

Noisly le Roi 78590

France

Main Telephone:

+33 (0)1 61 06 19 92

Website:

http://www.art-stent.com/

Type of Organization:

Private

PR

Industry:

Medical Devices

Key Executives:

CEO: Machiel van der Leest

Public Relations

Contact:

Ronald Trahan

Phone:

5083594005

Email:

rctrahan@ronaldtrahan.com




KEYWORDS: Europe France

INDUSTRY KEYWORDS:

The article Company Profile for Arterial Remodeling Technologies originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.